Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28431776 | 1.00 | LPAR3 (0.45) | LPAR3LPAR2LPAR1NAAACES2 | |
| SCHEMBL4398863 | 1.00 | LPAR3 (0.45) | LPAR3LPAR2LPAR1NAAACES2 | |
| SCHEMBL27769909 | 1.00 | LPAR3 (0.45) | LPAR3LPAR2LPAR1NAAACES2 | |
| SCHEMBL7640189 | 1.00 | LPAR3 (0.45) | LPAR3LPAR2LPAR1NAAACES2 | |
| SCHEMBL30030903 | 1.00 | LPAR3 (0.45) | LPAR3LPAR2LPAR1NAAACES2 | |
| Ammonia Solution, Strong SCHEMBL11851915 | 0.98 | LPAR3 (0.43) | LPAR3LPAR2LPAR1NAAACES2 | |
| Ammonia Solution, Strong SCHEMBL16204988 | 0.98 | LPAR3 (0.43) | LPAR3LPAR2LPAR1NAAACES2 | |
| SCHEMBL11446315 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL28742751 | 0.95 | LPAR3 (0.40) | LPAR3LPAR2LPAR1NAAACES2 | |
| Ether SCHEMBL10409109 | 0.92 | CES2 (0.42) | LPAR3LPAR2LPAR1NAAACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12115467-B2 | Amine separation method using liquid chromatography | DAICEL CORPORATION (JP) | 2024-10-15 | — | — | US | disclosed |
| US-20220339555-A1 | AMINE SEPARATION METHOD USING LIQUID CHROMATOGRAPHY | DAICEL CORPORATION (JP) | 2022-10-27 | — | — | US | disclosed |
| US-9968535-B2 | Personal care compositions comprising undecyl sulfates | THE PROCTER & GAMBLE COMPANY (US) | 2018-05-15 | — | — | US | disclosed |
| EP-2203150-B1 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | PROCTER & GAMBLE (US) | 2016-06-01 | — | — | EP | disclosed |
| CN-101835459-B | Personal care compositions comprising undecyl sulfates | PROCTER & GAMBLE | 2013-06-12 | — | — | CN | disclosed |
| CN-101835459-A | Personal care compositions comprising undecyl sulfates | PROCTER & GAMBLE | 2010-09-15 | — | — | CN | disclosed |
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | THE PROCTER & GAMBLE COMPANY | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | USP25, UTS2R, USP30 | LPAR3 2038/4885LPAR2 3214/4885LPAR1 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.